4.4 Article

Diverse immune evasion strategies by human cytomegalovirus

Journal

IMMUNOLOGIC RESEARCH
Volume 54, Issue 1-3, Pages 140-151

Publisher

HUMANA PRESS INC
DOI: 10.1007/s12026-012-8304-8

Keywords

Human cytomegalovirus; MHC antigen presentation; Immune evasion; Latency; Lytic infection; Unique short; Proteasome; Degradation

Categories

Funding

  1. American Heart Association
  2. DTRA [W81XWH-10-2-0048]
  3. Irma T. Hirschl Trust
  4. USPHS [T32-AI078892, T32-AI07647]
  5. Kadlec Medical Center Foundation
  6. Helmsley Fellowship

Ask authors/readers for more resources

Members of the Herpesviridae family have the capacity to undergo both lytic and latent infection to establish a lifelong relationship with their host. Following primary infection, human cytomegalovirus (HCMV) can persist as a subclinical, recurrent infection for the lifetime of an individual. This quiescent portion of its life cycle is termed latency and is associated with periodic bouts of reactivation during times of immunosuppression, inflammation, or stress. In order to exist indefinitely and establish infection, HCMV encodes a multitude of immune modulatory mechanisms devoted to escaping the host antiviral response. HCMV has become a paradigm for studies of viral immune evasion of antigen presentation by both major histocompatibility complex (MHC) class I and II molecules. By restricting the presentation of viral antigens during both productive and latent infection, HCMV limits elimination by the human immune system. This review will focus on understanding how the virus manipulates the pathways of antigen presentation in order to modulate the host response to infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available